Antibodies Used to Support Research into the Treatment of Ulcerative Colitis and Crohn’s Disease HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the release of a range of anti-vedolizumab antibodies. Vedolizumab (Entyvio) is a monoclonal antibody that is used to treat ulcerative

To read the full story...

Already a subscriber? Login now

< | >